Send Enquiry
EVERMED
Tablets
Packaging and packing Type
Alu Alu | 10x15
MRP :
₹148
PTR :
₹105.71
PTS :
₹95.14
An anti-diabetic drug that reduces glycemia in patients with type 2 diabetes mellitus. (B Ahrén, 2011) Enhances pancreatic islet cell responsiveness... Read More
Composition
Send Enquiry
India’s Largest Pharma Franchise
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
An anti-diabetic drug that reduces glycemia in patients with type 2 diabetes mellitus. (B Ahrén, 2011) Enhances pancreatic islet cell responsiveness to glucose. (Degrande, 2008) Improves the impaired sensitivity of the beta cells to glucose. (Foley, 2019) A well-tolerated and efficacious medicine in improving glycemic control in patients with type 2 diabetes mellitus. (Degrande, 2008) Provides superior efficacy and allows more patients to reach their glycemic targets. (Serge Halimi, 2008) Shows statistically significant and clinically meaningful reductions in HbA1c in patients with type 2 diabetes. (Serge Halimi, 2008) An effective therapy for glycemic control with a low risk of hypoglycemia. (L Cai, 2012) A safe option for managing patients with type 2 diabetes mellitus. (Chantal Mathieu, 2017) An efficacious candidate in reducing glycosylated hemoglobin, fasting plasma glucose, and postprandial glucose levels. (Prato, 2007) Provides superior efficacy to monotherapy treatments with a comparable overall tolerability profile and low risk of hypoglycemia in type 2 diabetes patients. (E Bosi, 2009)
Headache, Common cold, Cough, Constipation, Dizziness
Type 2 diabetes mellitus
Temp data
Storage Condition
Product details for storage condition Product details for storage condition Product details for storage condition Product details for storage condition
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner